Histopathologic consideration of fiducial gold markers inserted for real-time tumor-tracking radiotherapy against lung cancer

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):382-4. doi: 10.1016/j.ijrobp.2007.06.064. Epub 2007 Sep 19.

Abstract

Purpose: Internal fiducial gold markers, safely inserted with bronchoscopy, have been used in real-time tumor-tracking radiotherapy for lung cancer. We investigated the histopathologic findings at several points after the insertion of the gold markers.

Methods and materials: Sixteen gold markers were inserted for preoperative marking in 7 patients who subsequently underwent partial resection of tumors by video-assisted thoracoscopic surgery within 7 days.

Results: Fibrotic changes and hyperplasia of type 2 pneumocytes around the markers were seen 5 or 7 days after insertion, and fibrin exudation without fibrosis was detected 1 or 2 days after insertion.

Conclusions: Because fibroblastic changes start approximately 5 days after gold marker insertion, real-time tumor-tracking radiotherapy should be started >5 days after gold marker insertion.

MeSH terms

  • Adult
  • Aged
  • Female
  • Fibrosis
  • Foreign-Body Migration / pathology
  • Foreign-Body Reaction / pathology*
  • Gold*
  • Humans
  • Lung / pathology*
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Prostheses and Implants*
  • Radiotherapy / methods
  • Thoracic Surgery, Video-Assisted
  • Time Factors

Substances

  • Gold